Condition

Osteosarcoma

ClinicalTrials.gov condition label

Explore related research

Search across original and mapped records

Search results distinguish clinical terminology from original registry names. Shared trial participation does not imply treatment or approval.

How to interpret these research links

Connected source records

This is the original ClinicalTrials.gov condition label, found in 30 distinct published trials. It is kept separate from a MONDO disease identifier until a specific normalization is supported. Related interventions are co-recorded in studies; they are not medical recommendations.

Data basis: current published ClinicalTrials.gov records and, where present, RxNorm, MONDO and FDA-label identifiers. See the evidence interpretation and counting methodology.

Clinical trials30
Recruiting12
Common interventions25
Lead sponsors shown15
Advertisement

Clinical trials

30 shown
Atezolizumab in Combination With Stereotactic Body Radiation Therapy (SBRT) and Surgery for Relapsed OsteosarcomaNCT06492954 · 2026-10-01
RECRUITING
PET-imaging of Two Vartumabs in Patients With Solid TumorsNCT06645808 · 2024-12-10
RECRUITING
Agnostic Therapy in Rare Solid TumorsNCT06638931 · 2024-07-16
RECRUITING
Safety and Feasibility of Intraoperative Visualization With Cytalux in ChildrenNCT06235125 · 2024-04-08
RECRUITING
Pulmonary Resectable Osteosarcoma Treated by Metastasectomy and Pre-operative Immunotherapy and Stereotactic Body Radiotherapy (PROMIS): a Prospective Clinical TrialNCT06114225 · 2023-06-01
RECRUITING
Use of GnRHa During Chemotherapy for Fertility ProtectionNCT05328258 · 2023-03-31
RECRUITING
START: Safety and Anti-Tumor Activity of PeptiCRAd-1 in Treatment of CancerNCT05492682 · 2023-02-02
RECRUITING
AOH1996 for the Treatment of Refractory Solid TumorsNCT05227326 · 2022-08-12
RECRUITING
Thoracotomy Versus Thoracoscopic Management of Pulmonary Metastases in Patients With OsteosarcomaNCT05235165 · 2022-04-01
RECRUITING
Early Ageing During Therapy in AYA Cancer PatientsNCT05062707 · 2022-02-10
RECRUITING
Study of CRX100 as Monotherapy and in Combination With Pembrolizumab in Patients With Advanced Solid MalignanciesNCT04282044 · 2021-01-08
RECRUITING
Effects of Dexrazoxane Hydrochloride on Biomarkers Associated With Cardiomyopathy and Heart Failure After Cancer TreatmentNCT01790152 · 2014-03-05
RECRUITING
IBI188 Combination Therapy in Solid TumorsNCT04861948 · 2021-05-25
TERMINATED
Clinical Study of CD276 Targeted Autologous Chimeric Antigen Receptor T Cell Infusion in Patients With CD276 Positive Advanced Solid TumorNCT04864821 · 2021-05-14
UNKNOWN
The Registry of Oncology Outcomes Associated With Testing and TreatmentNCT04028479 · 2021-05-05
COMPLETED
A Post-treatment Program to Identify and Manage Complications Related to Oncology or Hematology Treatments in Cancer Survivors.NCT04671693 · 2020-12-24
ACTIVE_NOT_RECRUITING
Construction of Microfluidic Exosome Chip for Diagnosis of Lung Metastasis of OsteosarcomaNCT05101655 · 2020-10-01
COMPLETED
Pulmonary Resectable Metastases of Osteosarcoma With Anti-angiogenics and CHemotherapyNCT03742193 · 2019-08-11
UNKNOWN
Study of CB-103 in Adult Patients With Advanced or Metastatic Solid Tumours and Haematological MalignanciesNCT03422679 · 2017-12-05
TERMINATED
Vemurafenib in Treating Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With BRAF V600 Mutations (A Pediatric MATCH Treatment Trial)NCT03220035 · 2017-11-08
COMPLETED
Circulating Exosome RNA in Lung Metastases of Primary High-Grade OsteosarcomaNCT03108677 · 2017-05-01
UNKNOWN
Clinical Trial Evaluating Metronomic Chemotherapy in Patients With Metastatic OsteosarcomaNCT03063983 · 2017-01-02
UNKNOWN
Stereotactic Body Radiotherapy (SBRT) for Pulmonary Metastases in Ewing Sarcoma, Rhabdomyosarcoma, and Wilms TumorsNCT02581384 · 2017-01-01
TERMINATED
Bioequivalence & Food Effect Study in Patients With Solid Tumor or Hematologic MalignanciesNCT02223052 · 2014-10-27
COMPLETED
Study of Pazopanib in the Treatment of Osteosarcoma Metastatic to the LungNCT01759303 · 2013-04-01
TERMINATED
Intravenous Palifosfamide-tris in Combination With Etoposide and Carboplatin in Patients With MalignanciesNCT01242072 · 2010-12-01
COMPLETED
A Study of Pre-Operative Treatment of Newly-Diagnosed, Surgically-Resectable Osteosarcoma With Doxorubicin, Ifosfamide, Etoposide, and Cisplatin With Early Metabolic Assessment of ResponseNCT01258634 · 2010-07-01
TERMINATED
A Placebo-Controlled Study of Saracatinib (AZD0530) in Patients With Recurrent Osteosarcoma Localized to the LungNCT00752206 · 2009-03-01
TERMINATED
Safety and Efficacy Study of REOLYSIN® in the Treatment of Bone and Soft Tissue Sarcomas Metastatic to the LungNCT00503295 · 2007-06-01
COMPLETED
BLESSED: Expanded Access for DNG64-CAR-V for Advanced Pancreatic Cancer, Sarcoma and Carcinoma of BreastNCT04091295
AVAILABLE

Common interventions

Trial status mix

RECRUITING12
COMPLETED6
TERMINATED6
UNKNOWN4
ACTIVE_NOT_RECRUITING1
AVAILABLE1

Phase mix

PHASE111
PHASE210
EARLY_PHASE12
PHASE32
NA1
Advertisement

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.